In a pivotal randomised controlled trial, the BNT162b2 mRNA vaccine (tozinameran, Pfizer–BioNTech) showed 95% or greater efficacy against symptomatic and severe COVID-19 disease due to SARS-CoV-2. 1 ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

The mRNA metabolism passively shapes the levels of an mRNA modification called m6A within a steady-state cell and upon stress.

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian ...

For an industry bogged down in administrative tasks, AI can serve as a trusty assistant to ensure highly skilled, talented ...